Advertisement
Advertisement
LAB
Standard BioTools Inc. Common Stock
0.96
USDSponsored
0.00
-0.10%
Mar 26, 11:16 UTC -4
Open
LAB Earnings Reports
Positive Surprise Ratio
LAB beat 16 of 35 last estimates.
46%
Next Report
Date of Next Report
May 04, 2026
Estimate for Q1 26 (Revenue/ EPS)
$17.99M
/-$0.05
Implied change from Q4 25 (Revenue/ EPS)
-24.39%
/-200.00%
Implied change from Q1 25 (Revenue/ EPS)
-55.90%
/-28.57%
Standard BioTools Inc. Common Stock earnings per share and revenue
On Feb 24, 2026, LAB reported earnings of 0.05 USD per share (EPS) for Q4 25, beating the estimate of -0.07 USD, resulting in a 170.72% surprise. Revenue reached 23.80 million, compared to an expected 18.69 million, with a 27.33% difference. The market reacted with a 0.00% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of -0.05 USD, with revenue projected to reach 17.99 million USD, implying an decrease of -200.00% EPS, and decrease of -24.39% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
KORU Medical Systems, Inc. Common Stock (DE)
Report Date
Mar 12, 2026 For Q4 25
Estimate
-Actual
-$0.01
Surprise
-
CareCloud, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.03
Actual
$0.03
Surprise
-15.97%
Nyxoah SA Ordinary Shares
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.58
Surprise
-5.51%
Health Catalyst, Inc Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.09
Actual
$0.08
Surprise
-13.79%
Neuraxis, Inc.
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.21
Actual
-$0.17
Surprise
+22.48%
Heartflow, Inc. Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.17
Actual
-$0.12
Surprise
+30.31%
Heartbeam, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.13
Actual
-$0.14
Surprise
-0.72%
HeartSciences Inc. Common Stock
Report Date
Mar 16, 2026 For Q3 26
Estimate
-$0.86
Actual
-$0.63
Surprise
+27.34%
FAQ
What were Standard BioTools Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Standard BioTools Inc. Common Stock reported EPS of $0.05, beating estimates by 170.72%, and revenue of $23.80M, 27.33% above expectations.
How did the market react to Standard BioTools Inc. Common Stock's Q4 2025 earnings?
The stock price moved -- 0%, changed from $1.54 before the earnings release to $1.54 the day after.
When is Standard BioTools Inc. Common Stock expected to report next?
The next earning report is scheduled for May 04, 2026.
What are the forecasts for Standard BioTools Inc. Common Stock's next earnings report?
Based on 4
analysts, Standard BioTools Inc. Common Stock is expected to report EPS of -$0.05 and revenue of $17.99M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement